ASK REDCHAT ANYTHING ABOUT PALATIN TECHNOLOGIES INC.
Palatin Technologies Inc. (NYSE AMERICAN: PTN)
Listen to this Section
$14.02
+0.5200
(
+3.85% )
6.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Vyleesi® (bremelanotide) MC4r AgonistDetailsSexual dysfunction, Sexual desire disorder, Influenza |
Approved |
| PL9643DetailsDry eye syndrome, Eye disease |
Phase 3 |
| Bremelanotide + Tirzepatide (GLP-1)DetailsObesity, Metabolic disorder |
Phase 2 |
| PL8177 oral formulationDetailsChronic inflammatory disorder, Bowel disorder, Inflammatory disease, Ulcerative colitis |
Phase 2 |
| Bremelanotide + PDE5iDetailsErectile dysfunction |
Phase 2 |
| BremelanotideDetailsDiabetic Kidney Disease |
Phase 2 |
| PL3994 (NPR-A agonist)DetailsHeart disease |
Failed |
| PL8177 MC1r Agonist (Systemic)DetailsCOVID-19 |
Failed |
| PL8177DetailsEye disease , Inflammatory disease |
Failed |
| PL8177 oral formulationDetailsChronic inflammatory disorder, Inflammatory disease, Bowel disorder, Ulcerative colitis |
Phase 2 |
Market Data
|
| Open |
$14.02 |
| Previous Close |
$13.50 |
| Volume |
6.2K |
| Market Cap |
$24.02M |
| Day Range |
$13.72 - $14.54 |
| 52 Week Range |
$7.25 - $31.00 |
| Shares Outstanding |
1.78M |
| Change % |
+3.85% |
| Net Change |
▲ 0.5200 |
| Insider Ownership |
0.00% |
| Exchange |
NYSE AMERICAN |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 1993 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-126,706.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-12-06 |
Sale |
-199.00 |
DUNTON ALAN W |
| 2023-08-16 |
Sale |
-2331.00 |
SPANA CARL |
| 2023-08-16 |
Sale |
-1527.00 |
WILLS STEPHEN T |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
20 |
Nov 12, 2025 |
| 8-k |
8K-related |
19 |
Nov 06, 2025 |
| 10-k |
Annual reports |
84 |
Sep 23, 2025 |
| 8-k |
8K-related |
15 |
Sep 22, 2025 |
| 8-k |
8K-related |
14 |
Sep 10, 2025 |
| 8-k |
8K-related |
17 |
Aug 18, 2025 |
| 8-k/a |
8K-related |
14 |
Aug 11, 2025 |
| 8-k |
8K-related |
16 |
Aug 08, 2025 |
| 8-k |
8K-related |
14 |
Jul 29, 2025 |
| 8-k |
8K-related |
14 |
Jul 09, 2025 |